Annual Drug Patent Expirations for BYLVAY
Bylvay is a drug marketed by Albireo and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and nineteen patent family members in forty-six countries.
The generic ingredient in BYLVAY is odevixibat. Additional details are available on the odevixibat profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
